Image description

Published yearly: 

4 Issues

______________________

ISSN: 2320-964X (Online) 

ISSN: 2320-7817  (Print)

______________________

Editor-in-Chief

Dr. Santosh Pawar 


INDEXED IN

RESEARCH ARTICLE

_______________________________________________________________________________________

Int. Journal of Life Sciences, 2018; 6(2): 665-680      |                 Available online, April 28, 2018

Diabetes: The next epidemic?


Mehra Varsha 1*, Mishra Smita 2, Gupta Nomita 3 and Khatri Manisha 1

 

*1Assistant Professor, Department of Biomedical Sciences, Shaheed Rajguru College of Applied Sciences, University of Delhi

2PhD fellow, Department of Biomedical Sciences, Shaheed Rajguru College of Applied Sciences, University of Delhi

3Project trainee in Department of Biomedical Sciences, Shaheed Rajguru College of Applied Sciences, University of Delhi

 Email: varsha.mehra@rajguru.du.ac.in| Tel: 91-11-9971703464

   

Received :10.11.2017   |    Revised : 06.02.2018   |    Accepted : 18.04.2018  |   Published : 28.04.2018

Since the evolution of mankind, numerous disease have arisen and many got eradicated. Some of the deadly diseases became history and some became epidemic. Diabetes is one of those diseases which has arisen almost with advent of the human civilization and continues to persist in our society. Existence of diabetes goes back to Vedic and Greek period, where diagnosis was done by tasting urine. Although, it is neither caused by any microbial infection nor is it contagious, yet the disease is rampant in the society and rapidly spreading across the globe. The disease is characterized by hyperglycemia and glycosuria. Although it can be managed by using commercially available drugs, the treatment is often lifelong and requires lifestyle management. If undiagnosed, the disease could lead to severe late stage complications such as neuropathy, retinopathy and nephropathy. These late stage complications are often fatal, contributing to mortality associated with the disease. Around 422 million people are afflicted with diabetes worldwide. India is perhaps one of the highest contributors to diabetes population. The present review is an attempt towards understanding the disease, its mechanism and complications, diagnosis, treatment and looking at the alternative natural plant based therapies. 

 

Keywords: Hyperglycemia, Glycosuria, AGES, Metformin, Plant based drug approach and Diabetes co-infection

 

_________________________________________________________________________

Editor: Dr.Arvind Chavhan

___________________________________________________________________________________ 

Cite this article as:

Mehra Varsha, Mishra Smita, Gupta Nomita and Khatri Manisha (2018) Diabetes: The next epidemic, Int. J. of. Life Sciences, Volume 6(2): 665-680. 

____________________________________________________________________________

Acknowledgement

The present review is a result of plant based research on anti-diabetic innovation project SRCA-307, funded by University of Delhi. The authors are thankful to University of Delhi, for giving them the opportunity to contribute in their small way, to Diabetes research.

____________________________________________________________________________


Conflicts of interest: The authors stated that no conflicts of interest.

____________________________________________________________________________

 

Copyright: © 2018 | Author(s), This is an open access article under the terms of the Creative Commons Attribution-Non-Commercial - No Derives License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

_________________________________________________________________________

 

Olokoba AB, Obateru OA, Olokoba LB (2012) Type 2 Diabetes Mellitus: A Review of Current Trends. Oman Med. Journal.27(4):269-273. doi:10.5001/omj.2012.68.


Ramachandran A (2014) Know the signs and symptoms of diabetes. The Indian Journal of Med. Research.140(5):579-581.


Taylor R (2013) Type 2 Diabetes: Etiology and reversibility. Diabetes Care. 36(4):1047-1055.

WHO diabetes report (2016) cited on May 2017, available at   http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf


McCarthy N (2016) The unrelenting global march of Diabetes; cited on May 2017; https://www.statista.com/chart/4617/the-unrelenting-global-march-of-diabetes/.


Hu FB (2011) Globalization of Diabetes: The role of diet, lifestyle, and genes. Diabetes Care.34(6):1249-1257.

Yang W, Lu J, Weng J, Jia W et al (2010) China National Diabetes and Metabolic Disorders Study Group.N Engl J Med.362(12):1090-101.


Kaveeshwar SA, Cornwall J (2014) The current state of diabetes mellitus in India. The Australasian Med. Journal.7(1):45-48. doi:10.4066/AMJ.2013.1979.


Sonksen P, Sonksen J (2000) Insulin: understanding its action in health and disease; Br J Anaesth. 85 (1): 69–79. PMID 10927996


Berg JM, Tymoczko JL, Stryer L. (2002) Biochemistry. 5th edition. New York: W H Freeman. Available from: https://www.ncbi.nlm.nih.gov/books/NBK21154/


Diagnosis and Classification of Diabetes Mellitus (2014 Jan; 37) American Diabetes Association:Diabetes Care (Supplement 1): S81-S90. https://doi.org/10.2337/dc14-S081


White JR (2014) “A Brief History of the Development of Diabetes Medications.” Diabetes Spectrum : A Publication of the ADA.27(2): 82–86. PMC.


Owens DR (2012) Human Insulin: Clinical Pharmacological Studies in Normal Man. Springer Sci. & Business Media.pp. 134–136. ISBN 9789400941618.


Noble SL, Johnston E, and Walton B (1998) Insulin Lispro: A Fast-Acting Insulin Analog. Am Fam Physician.57(2):279-286.


"Aspart insulin (rDNA origin) injection". Updated on 15/12/2017; Available on https://web.archive.org/web/20070610074313/http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a605013.html retrieved on 2017-07-28


“Apidra insulin glulisine (rDNA origin) injection". Updated on June 2017; Available on https://www.apidra.com/default.aspx; Retrieved 2017-07-08


Brunetti L, and Kalabalik J (2012) “Management of Type-2 Diabetes Mellitus in Adults: Focus on Individualizing Non-Insulin Therapies.”; Pharm. and Therap.37(12): 687–696.


Chaudhury A, Duvoor C, Reddy Dendi VS, et al. (2017) Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management. Frontiers in Endocrinol.8:6. doi:10.3389/fendo.2017.00006.


Kuritzky L. (2006) Addition of Basal Insulin to Oral Antidiabetic Agents: A Goal-Directed Approach to Type 2 Diabetes Therapy.Medscape General Med.8(4):34.


Sena CM, Bento CF, Pereira P, Seiça R (2010) Diabetes mellitus: new challenges and innovative therapies.The EPMA Journal.1(1):138-163. doi:10.1007/s13167-010-0010-9.


Karter AJ, Moffet HH, Liu J, et al. (2005) Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry.The American journal of managed care.11(4):262-270.


Luna B and Feinglos M N (2001) Oral Agents in the Management of Type 2 Diabetes Mellitus. Am Fam Physician.63(9):1747-1757.


American Diabetes Association. What are my options? Updated on March 2015, Retrieved on 26/06/2017. Available at

http://www.diabetes.org/living-with-diabetes/treatment-and-care/medication/oral-medications/what-are-my-options.html

 

BYDUREON- exenatide; US National Library of Medicine; Updated on October 2017, Retrieved on 26/06/2017; Available at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=71fe88be-b4e6-4c2d-9cc3-8b1864467776


Byetta – exenatide injection. Retrieved on 26/06/2017. Available at  http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=751747da-7c1f-41ad-b1a6-a6d920f70599 Retrieved on 2017-03-05


Diabetes treatment: Medications for type 2 diabetes. Updated on September 2017; Available at

http://www.mayoclinic.org/diseases-conditions/type-2-diabetes/in-depth/diabetes-treatment/ART-20051004?pg=2 Retrieved on 2017-11-10


Mayo Clinic Staff. (2017, August 7). Type 1 diabetes: Treatments and drugs. Available at http://www.mayoclinic.org/diseases-conditions/type-1-diabetes/basics/treatment/con-20019573 Retrieved on 2017-03-10

 

National Institute of Diabetes and Digestive and Kidney Diseases. (2016, May). Diabetes medicines. Available at http://diabetes.niddk.nih.gov/dm/pubs/medicines_ez/ Retrieved on 2017-03-11


Victoza – liraglutide injection. Updated on January 2018; Retrieved on 8 February 2018; Available at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a9ef 4ea-c76a-4d34-a604-27c5b505f5a4

Singh BB, Khorsan R, Vinjamury SP, Der-Martirosian C, Kizhakkeveettil , Anderson TM (2007) Herbal Treatments of Asthma: A Systematic Review. Journ. of Asthm.44(9): 685-698.


Shirazi M T, Gholami H, Kavoosi G, Rowshan V, Tafsiry A (2014) Chemical composition, antioxidant, antimicrobial and cytotoxic activities of Tagetes minuta and Ocimum basilicum essential oils; Food Sci. & Nutri.2(2): 146–155.


Elder C (2004) Ayurveda for Diabetes Mellitus: A Review of the Biomedical Literature; Alternative Therapies in Health and Medicine; Aliso Viejo.10(1): 44-50.


Bala V. Manyam (2004) Diabetes Mellitus, Ayurveda, and Yoga. The Journ. of Alt. and Complementary Med. 10(2): 223-225. https://doi.org/10.1089/107555304323062185


Welihinda J, Karunanayake E.H, Sheriff M.H.H, Jayasinghe K.S.A (1986) Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes; Journal of Ethnopharmaco.17(3): 277-28.


Tripathi U N and Chandra D (2009) The plant Extracts of Momordica Charantia and Trigonella Foenum Graecum have Antioxidant and Anti-Hyperglycemic Properties for Cardiac Tissue During Diabetes Mellitus; Oxidative Med. and Cell. Long.2(5): 290-296.


Li Y, Tran HV, Duke CC, and Roufogalis BD (2012) “Preventive and Protective Properties of Zingiber officinale (Ginger) in Diabetes Mellitus, Diabetic Complications, and Associated Lipid and Other Metabolic Disorders: A Brief Review,” Evidence-Based Complement. and Alt. Medicine; vol. 2012, Article ID 516870, 10 pages. doi:10.1155/2012/516870


Ranasinghe P, Perera S, Gunatilake M, et al. (2012) Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat model. Pharmacognosy Res.4(2):73-79. doi:10.4103/0974-8490.94719.


Tembhurne SV, Sakarkar DM (2010) Influence of Murraya koenigii on experimental model of diabetes and progression of neuropathic pain. Research in Pharm. Sci. 5(1):41-47.


Nair RB, Santhakumari G. (1.986) Anti-Diabetic activity of the seed kernel of Syzygium cumin Linn.Ancient Science of Life.6(2):80-84.


Soren G, Sarita M and Prathyusha T (2016) Antidiabetic activity of Actinidia deliciosa fruit in alloxan induced diabetic rats; The Pharma Innovation Journal.5(9): 31-34.


Baskaran K, KizarAhamath B, RadhaShanmugasundaram K, Shanmugasundaram ERB (1990) Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients; Journal of Ethnopharmaco. 30(3):295-305.


Shibib A, Khan LA, Rahman R (1993) Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenaseB; Biochem. Journal. 292(1):267-270; DOI: 10.1042/bj2920267.


Khosla P, Bhanwra S, Singh J, Seth S and Srivastava R K (2000) A Study of Hypoglycemic effects of Azadirachta indica (Neem) in normal and Alloxan Diabetic rabbits; Indian J Physiol Pharmacol.44 (1): 69-74.


Elfellah M S, Akhter M H, Khan M T (1984) Anti-hyperglycaemic effect of an extract of Myrtus communis in streptozotocin-induced diabetes in mice; Journal of Ethnopharmaco.11(3):275-281.


Mohaddese M (2017) Effectiveness of Myrtus communis in the treatment of hemorrhoids, Journal of Integrat. Med.15(5):351.


Amalraj T, Ignacimuthu S (1998) Evaluation of the hypoglycaemic effect of Memecylon umbellatum in normal and alloxan diabetic mice; Journal of Ethnopharmaco. 62(3):247-250.


Andallu B, Vinay Kumar AV, Varadacharyulu NC (2009) Lipid abnormalities in streptozotocin -diabetes: Amelioration by Morus indica L. cv Suguna leaves; Int. J of Diabetes in Developing Countries.29(3):123-128.


Chattopadhyay RR (1993) Hypoglycemic effect of Ocimum sanctum leaf extract in normal and streptozotocin diabetic rats.; Indian J of Experimental Biology. 31(11):891-893.


Subramoniam A, Pushpangadan P, Rajasekharan S, Evans DA, Latha PG, Valsaraj R (1996) Effects of Artemisia pallens Wall. on blood glucose levels in normal and alloxan-induced diabetic rats; Journal of Ethnopharmaco.50(1):13-17.


Alarcon-Aguilar FJ, Roman-Ramos R, Flores-Saenz JL and Aguirre-Garcia F (2002) Investigation on the hypoglycaemic effects of extracts of four Mexican medicinal plants in normal and Alloxan-diabetic mice. Phytother. Res.16: 383–386.


Ajayi AF, Akhigbe RE, Adewumi OM, Okeleji LO, Mujaidu KB, Olaleye SB (2012) Effect of ethanolic extract of Cryptolepis sanguinolenta stem on in vivo and in vitro glucose absorption and transport: Mechanism of its antidiabetic activity. Indian Journal of Endocrinol. and Met.16(Suppl1):S91-S96. doi:10.4103/2230-8210.94265.


Pandita R, Phadkeb A, Jagtap A (2010) Antidiabetic effect of Ficus religiosa extract in streptozotocin-induced diabetic rats; Journal of Ethnopharmaco.128(2):462-466.


Murali B, Upadhyaya U M, Goyal R K (2002) Effect of chronic treatment with Enicostemma littorale in non-insulin-dependent diabetic (NIDDM) rats; Journal of Ethnopharmaco.81(2):199-204.


Zhang X.-F. and Tan B K.-H. (2000) Antihyperglycaemic And Anti-Oxidant Properties Of Andrographis Paniculata In Normal And Diabetic Rats. Clinical and Experimental Pharmaco and Physio.27: 358–363.


Islam MS and Choi H (2008) Dietary red chilli (Capsicum frutescens L.) is insulinotropic rather than hypoglycemic in type 2 diabetes model of rats. Phytother. Res.22: 1025–1029.


Roy DC, Shark Md. M, Faruquee Md. H (2013) A Brief Review On Phytochemistry and Pharmacological Properties of Adhatoda vasica; Journal of Trop. Medic. Plants. 14:115-124.


Mohammadi J, Naik PR (2008) Evaluation of hypoglycemic effect of Morus alba in an animal model. Indian Journal of Pharmaco.40(1):15-18. doi:10.4103/0253-7613.40483.


Bisht S, Sisodia SS (2011) Assessment of antidiabetic potential of Cinnamomum tamala leaves extract in streptozotocin induced diabetic rats. Indian Journal of Pharmaco. 43(5):582-585. doi:10.4103/0253-7613.84977.

 

Bhattacharya SK (1995) Shilajit attenuates streptozotocin induced diabetes mellitus and decrease in pancreatic islet superoxide dismutase activity in rats. Phytother. Research. 9(1):41–44.


Patel SS, Goyal RK (2011) Prevention of diabetes-induced myocardial dysfunction in rats using the juice of the Emblica officinalis fruit. Experimental & Clinical Cardio. 16(3):87-91.


Sharma S, Kulkarni SK and Chopra K (2006) Curcumin, The Active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clinical and Experimental Pharmaco. and Physio.33: 940–945.


Patil R N, Patil R Y, Ahirwar B, Ahirwar D (2011) Evaluation of antidiabetic and related actions of some Indian medicinal plants in diabetic rats; Asian Pacific Journal of Tropic. Med.4(1):20-23


Wang ET, Calderon-Margalit R, Cedars MI, Daviglus ML et al (2011) Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia.; Obstet Gynecol.117(1):6-13. doi: 10.1097/AOG.0b013e31820209bb


Cibula D, Cifkova R, Fanta M, Poledne R, et al (2000) Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.; Human reproduction.15(4): 785-789.


Dooley KE, Chaisson RE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet infect. diseases.9(12):737-746.


Olmos P, Donoso J, Rojas N, et al (1989) Tuberculosis and diabetes mellitus: a longitudinal-retrospective study in a teaching hospital. Rev Med Chil.117:979–83.


Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG (1995) Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis.76:529–33.


Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults.; Am J Epidemiol. 159(12):1160-7.


Vigneri PG, Tirrò E, Pennisi MS, et al (2015) The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy.; Front. Onc.5:230.


Butler PC, Dry S, Elashoff R (2010) GLP-1–Based Therapy for Diabetes: What You Do Not Know Can Hurt You; Diabetes Care.33(2):453-455.


Kalra S, Kalra B, Agrawal N, Unnikrishnan A (2011) Understanding diabetes in patients with HIV/AIDS; Diabet. Met Syn. 3:2. doi:10.1186/1758-5996-3-2.


Singhal A, Jie L, Kumar P, Hong GS, Leow M. K.-S. et al (2011) Metformin as adjunct antituberculosis therapy. Science Translational Medicine.6(263):263ra159

DOI: 10.1126/scitranslmed.3009885

 

 

IJLSCI EVENTS

ADVERTISEMENT

 
















    INTERNATIONAL JOURNAL OF

    LIFE SCIENCES

    Origin & Evolution

    Print ISSN : 2320-7817 

    Online ISSN:2320-964X

    UGC Approved Journal No. 48951


    EDITORIAL OFFICE

    46, Guruwandan, Jawahar Nagar, 

    VMV Road, Amravati- 444604

    Maharashtra, India.

    Tel  + 91- 9970559438  |   9420775527  

    Email: editor@ijlsci.in | editorijlsci@gmail.com